Endometrioma. Endometriosis of ovary
Conditions
Interventions
Intervention 1: Intervention group: Received medroxyprogesterone 20 mg with Bromocriptine 1/25 mg twice daily for at least 3 months. Intervention 2: Control group: Received medroxyprogesterone 20 mg
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: A definitive diagnosis of endometrioma
Exclusion criteria
Exclusion criteria: patients with hyperprolactinemia People with coagulation disorders who have contraindications to medroxyprogesterone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrioma size. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: Ultrasonography.;Pain pelvic. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dysmenorrhea. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test.;Dyspareunia. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahereh Poordast
Shiraz University of Medical Sciences
Outcome results
None listed